Pular para o conteúdo
Fasceíte eosinofílica
ORPHA:3165CID-10 · M35.4CID-11 · 4A43.4OMIM 226350DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
MuscularInício adultaHerança Unknown
Também conhecida comoSíndrome Shulman
Sinônimos clínicos: Síndrome Shulman

A Fascite Eosinofílica é uma doença rara do tecido conjuntivo (que dá suporte ao corpo) caracterizada pela inflamação e espessamento da fáscia (o tecido que envolve os músculos), geralmente associada a um aumento de um tipo de célula de defesa do sangue chamada eosinófilo. Ela geralmente se manifesta em adultos com inchaço simétrico e doloroso, principalmente nos braços e nas pernas, que com o tempo se tornam endurecidos. Cansaço, endurecimento da pele que pode causar limitações, inflamação dos músculos (miosites) e inflamação nas articulações (artrite) também podem ser observados.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

A **fasceíte eosinofílica**, também chamada de síndrome Shulman, é uma doença rara que causa inflamação e endurecimento da fáscia, o tecido fibroso que protege os músculos. Geralmente manifesta-se em adultos provocando inchaço doloroso nos braços e nas pernas, além de cansaço excessivo e dores nas articulações. Nos exames de laboratório, é muito frequente encontrar um aumento de eosinófilos, que são células de defesa presentes no sangue. No Brasil, a doença não conta com um protocolo próprio ou medicamentos específicos dispensados pelo SUS por meio de PCDT, mas o acompanhamento é realizado pelos serviços de saúde de referência.

📋
Informacoes curadas por IA — podem conter imprecisoes

A Fascite Eosinofílica é uma doença rara do tecido conjuntivo (que dá suporte ao corpo) caracterizada pela inflamação e espessamento da fáscia (o tecido que envolve os músculos), geralmente associada a um aumento de um tipo de célula de defesa do sangue chamada eosinófilo. Ela geralmente se manifesta em adultos com inchaço simétrico e doloroso, principalmente nos braços e nas pernas, que com o tempo se tornam endurecidos. Cansaço, endurecimento da pele que pode causar limitações, inflamação dos músculos (miosites) e inflamação nas articulações (artrite) também podem ser observados.

Pesquisas ativas
1 ensaio
7 total registrados no ClinicalTrials.gov
Publicações científicas
937 artigos
Último publicado: 2026 Apr 13

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adult
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: M35.4
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🩸
Sangue
3 sintomas
💪
Músculos
2 sintomas
📏
Crescimento
1 sintomas
🧬
Pele e cabelo
1 sintomas

+ 11 sintomas em outras categorias

Características mais comuns

90%prev.
Edema
Muito frequente (99-80%)
90%prev.
Celulite
Muito frequente (99-80%)
90%prev.
Eosinofilia
Muito frequente (99-80%)
90%prev.
Anormalidade dos eosinófilos
Muito frequente (99-80%)
90%prev.
Fadiga
Muito frequente (99-80%)
90%prev.
Mácula
Muito frequente (99-80%)
18sintomas
Muito frequente (10)
Frequente (2)
Ocasional (4)
Sem dados (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 18 características clínicas mais associadas, ordenadas por frequência.

Muito frequente (99-80%)90%
CeluliteCellulitis
Muito frequente (99-80%)90%
EosinofiliaEosinophilia
Muito frequente (99-80%)90%
Anormalidade dos eosinófilosAbnormality of eosinophils
Muito frequente (99-80%)90%
FadigaFatigue
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico937PubMed
Últimos 10 anos200publicações
Pico202552 papers
Linha do tempo
2026Hoje · 2026🧪 2006Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
1Fase 11
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Fasceíte eosinofílica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 13 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

7 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
353 papers (10 anos)
#1

Eosinophilic Fasciitis in Pediatric Patients: A Rare but Distinct Autoimmune Fibrosing Disorder.

Pediatrics in review2026 Mar 01

Eosinophilic fasciitis (EF), or Shulman syndrome, first described in 1974, is a rare fibrosing disorder characterized by painful, symmetric swelling and progressive woody induration of skin and subcutaneous tissues. Although the pathogenesis remains unclear, EF is considered immune-mediated, often triggered by physical exertion, infections, or medications. Pediatric EF, a particularly uncommon subset, can exhibit distinct clinical features, including pronounced extracutaneous manifestations, unpredictable disease progression, and variable therapeutic responses. Clinical presentations range from rapidly advancing fibrosis leading to joint contractures to fluctuating inflammatory episodes. Diagnosis is challenging because of the absence of universal criteria, although peripheral eosinophilia, elevated inflammatory markers, and imaging findings support clinical suspicion. Definitive diagnosis depends on deep skin and fascial biopsy, revealing eosinophil-rich lymphoplasmacytic infiltrates and fibrosis. Management primarily relies on systemic corticosteroids, supplemented by steroid-sparing immunosuppressive medications in refractory cases. Early diagnosis and treatment are critical because untreated EF can cause irreversible fibrosis and significant functional impairment. The disease's rarity, heterogeneous presentations, and unclear etiology further complicate clinical management. Recent insights suggest EF may involve intricate interactions among environmental triggers, immune dysregulation, and fibrotic remodeling. This review aims to provide an updated overview of pediatric EF, highlighting current knowledge on clinical manifestations, diagnosis, differential diagnosis, therapeutic approaches, and outcomes, supported by an illustrative case, with emphasis on areas needing further research.

#2

Eosinophilic Fasciitis.

JAMA dermatology2026 Mar 01

This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.

#3

Two case reports of eosinophilic fasciitis with onset after immune checkpoint inhibitor cessation.

Frontiers in oncology2026

Immune checkpoint inhibitors (ICIs) are known to cause a wide spectrum of immune-related adverse events (irAEs). Among these, eosinophilic fasciitis (EF) is a rare, fibrosing disorder causing inflammatory infiltration of subcutaneous fat and fascia. It is characterized clinically by edema and subsequent induration and tightening of the skin and subcutaneous tissues. Several case reports have documented EF secondary to ICIs in patients on active treatment. Herein, we present two cases of delayed EF following treatment cessation with avelumab for metastatic urothelial carcinoma (Case 1) and following adjuvant nivolumab completion for stage IIIC melanoma (Case 2). Both patients had typical exam findings including erythema/edema of the extremities and trunk and diffuse thickening of subcutaneous fat and fascia, leading to severe respiratory restriction in Case 1. Both patients were diagnosed with EF by full-thickness skin biopsy showing sclerosis and lymphocytic infiltration of the subcutaneous fat and/or fascia. Only one of the two patients presented with definite eosinophilia. Both cases were treated with glucocorticoids and had early recurrence of symptoms post steroid taper, necessitating subsequent protracted steroid and steroid sparing agent use. Overall, we demonstrate the importance of considering delayed irAEs, specifically autoimmune fibrotic skin diseases even when ICI therapy has been discontinued. We underscore the need for collaboration between oncology and rheumatology as the scope of ICI treatments for cancer continues to expand.

#4

[Shulman syndrome: An atypical presentation of a rare disease].

Revista medica del Instituto Mexicano del Seguro Social2026 Mar 03

Eosinophilic fasciitis is a rare scleroderma-like disorder. Most of the available information comes from case reports or small case series. It is characterized by fascial thickening, acute pain, skin induration, joint contractures, and, anecdotally, visceral involvement. Diagnosis is confirmed through deep biopsy, although magnetic resonance imaging may be useful in inconclusive cases. We describe the case of a previously healthy 32-year-old man male with a history of recurrent minor trauma to the lumbar and gluteal regions. He developed acute-onset pain and progressive deep induration in the affected regions, which later extended symmetrically to all four extremities. Initial magnetic resonance imaging suggested lymphedema; however, given the high clinical suspicion, images were re-evaluated, revealing findings consistent with fasciitis. Treatment with corticosteroids and methotrexate was initiated, resulting in rapid improvement of residual pain and gradual reduction of deep induration. This case highlights the heterogeneous presentation of eosinophilic fasciitis and underscores the importance of including it in the differential diagnosis of scleroderma-like disorders, as well as the role of magnetic resonance imaging in ambiguous cases. la fascitis eosinofílica es un trastorno esclerodermiforme poco frecuente. La mayor parte de la información disponible proviene de reportes y series de casos. Se caracteriza por engrosamiento de la fascia, dolor agudo, endurecimiento cutáneo, contracturas articulares y, de manera anecdótica, compromiso orgánico. El diagnóstico se confirma mediante biopsia profunda; sin embargo, la resonancia magnética puede ser de utilidad en casos no concluyentes. se describe el caso de un hombre de 32 años, previamente sano, con antecedente de trauma leve repetido en la región lumbar y glútea. El paciente desarrolló dolor súbito e induración profunda progresiva en las regiones comprometidas, con extensión posterior y simétrica a las cuatro extremidades. La resonancia magnética inicial sugirió linfedema; no obstante, ante la alta sospecha clínica, se realizó una reinterpretación del estudio, evidenciándose hallazgos sugestivos de fascitis. Se inició tratamiento con esteroides y metotrexato, con rápida mejoría del dolor residual y disminución paulatina de la induración profunda. este caso destaca la presentación heterogénea de la fascitis eosinofílica y la importancia de considerarla dentro del diagnóstico diferencial de los trastornos esclerodermiformes, así como el papel relevante de la resonancia magnética en escenarios diagnósticos ambiguos.

#5

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report.

Clinical case reports2026 Jan

Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40-year-old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long-term safety for EF.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC728 artigos no totalmostrando 189

2026

Ischemic stroke despite therapeutic anticoagulation in eosinophilic fasciitis with compartment syndrome and deep vein thrombosis: a case report.

Thrombosis journal
2026

Two case reports of eosinophilic fasciitis with onset after immune checkpoint inhibitor cessation.

Frontiers in oncology
2026

[Shulman syndrome: An atypical presentation of a rare disease].

Revista medica del Instituto Mexicano del Seguro Social
2026

Eosinophilic Fasciitis in Pediatric Patients: A Rare but Distinct Autoimmune Fibrosing Disorder.

Pediatrics in review
2026

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report.

Clinical case reports
2025

Idiopathic inflammatory myopathies: a comprehensive review, new concepts on diagnostic imaging and whole-body MRI.

European radiology
2026

[Eosinophilic fascitis: A case report and literature review].

Revista medica del Instituto Mexicano del Seguro Social
2025

[A typical myofascial pain syndrome, or perhaps not? : Rare differential diagnosis].

Innere Medizin (Heidelberg, Germany)
2025

[POEMS syndrome misdiagnosed as systemic sclerosis: A case report].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2025

Eosinophilic Fasciitis in a Young Adult: A Rare Presentation Potentially Triggered by the Epstein-Barr Virus.

Cureus
2026

The utility of rituximab in patients with eosinophilic fasciitis: case series from an Australian tertiary multidisciplinary clinic.

Clinical rheumatology
2025

Enterohepatic Non-H. pylori Helicobacter Infection in a Patient With X-Linked Agammaglobulinemia.

Pediatric dermatology
2025

Eosinophilic fasciitis: A case report and literature review.

Medicine
2025

A phase 2b basket trial approach to treat multiple rare and fibrotic skin diseases.

Frontiers in medicine
2025

Eosinophilic Fasciitis in a 78-Year-Old Man Following Pembrolizumab Treatment for Bladder Cancer.

The American journal of case reports
2025

Nivolumab-Induced Fasciitis Mimicking Scleroderma: A Diagnostic Challenge.

Cureus
2025

Eosinophilic fasciitis associated with Sjögren's disease: a rare case.

Scandinavian journal of rheumatology
2025

Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising Clinicians.

Journal of clinical medicine
2026

Clinicopathological Challenge: A Progressively Enlarging Hardened Skin Plaque.

International journal of dermatology
2025

Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature.

Clinical medicine &amp; research
2025

Coexistence of eosinophilic fasciitis and systemic lupus erythematosus: a case-based review.

Modern rheumatology case reports
2025

Eosinophilic Fasciitis with Isolated Hand Involvement: A Diagnostic Challenge.

Archives of rheumatology
2025

Diagnosis and treatment of early eosinophilic fasciitis: a case report.

Journal of medical case reports
2025

Localized scleroderma: multiparametric MRI with diffusion-weighted imaging and gadolinium-based perfusion imaging for assessing disease activity.

Skeletal radiology
2025

Eosinophilic Fasciitis: New Developments and Future Directions.

International journal of dermatology
2026

Eosinophilic Fasciitis and Morphea Share Gene Signatures of Inflammatory Cell Death, Self-DNA Recognition, and Enhanced Jak/Signal Transducer and Activator of Transcription Signaling.

The Journal of investigative dermatology
2025

Recurrent Eosinophilic Fasciitis: The First Case Report.

Clinical, cosmetic and investigational dermatology
2025

Immune checkpoint inhibitor-related eosinophilic fasciitis: 3 case reports with literature review.

La Revue de medecine interne
2025

Clinicopathological profile of eosinophilic fasciitis: a retrospective cohort study from a neuromuscular disorder center in China.

Arthritis research &amp; therapy
2025

Treatment Outcomes of Eosinophilic Fasciitis: A Systematic Review.

Journal of cutaneous medicine and surgery
2025

Eosinophilic fasciitis following postpartum: A rare case report.

The Journal of international medical research
2025

A case report on the implantation of a leadless pacemaker in a patient with eosinophilic fasciitis and third-degree atrioventricular block.

BMC cardiovascular disorders
2025

[Analysis of ultrasound as an adjunctive diagnostic tool for eosinophilic fasciitis].

Zhonghua nei ke za zhi
2025

Navigating complexity through "the groove": eosinophilic fasciitis in the context of diabetes and lichen planus.

Journal of rheumatic diseases
2025

Localized scleroderma: anatomic MRI findings of morphea with inter-reader analysis.

Skeletal radiology
2025

Unilateral Eosinophilic Fasciitis With Hand Involvement: A Case Report.

Clinical case reports
2025

Treatment and Monitoring of Eosinophilic Fasciitis.

Current treatment options in rheumatology
2025

Eosinophilic fasciitis induced by immune checkpoint inhibitors successfully controlled with dapsone.

European journal of dermatology : EJD
2025

Overlap of generalized morphea and eosinophilic fasciitis after recreational exposure to epoxy resin.

JAAD case reports
2025

Characteristics and factors associated with treatment response among patients with eosinophilic fasciitis: a systematic review and meta-analysis.

Rheumatology international
2025

Eosinophil-induced adverse events induced by treatment with programmed cell death 1/ligand 1 inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system.

International journal of cancer
2025

[Target organ connective tissue: the variability of systemic fibrosis].

Innere Medizin (Heidelberg, Germany)
2025

[Mysterious connective tissue disease: Eosinophilic Fasciitis].

MMW Fortschritte der Medizin
2025

Case Series: Extracutaneous Findings of Eosinophilic Fasciitis Patients.

International journal of rheumatic diseases
2025

Eosinophilic Fasciitis: A Case Series.

Cureus
2025

Restricted Movement Associated with Unilateral Diffuse Fasciitis.

Internal medicine (Tokyo, Japan)
2025

A Challenging Case of Eosinophilic Fasciitis Without Classic Histopathological Findings.

The Permanente journal
2025

Unraveling Shulman's syndrome: A rare case of eosinophilic fasciitis in a pediatric patient with fascial abnormalities on MRI.

Radiology case reports
2025

Pediatric eosinophilic fasciitis: similarities and differences with adult forms.

European journal of pediatrics
2025

Clinical Images: Groove sign: heeding clue to eosinophilic fasciitis.

ACR open rheumatology
2024

Eosinophilic fasciitis, a rare cause of skin thickening: a case report.

ARP rheumatology
2025

18F-FDG PET/CT: The turning point in eosinophilic fasciitis diagnosis in a pediatric patient.

European journal of nuclear medicine and molecular imaging
2024

Eosinophilic fasciitis and breast cancer: a case report highlighting recurrence signals.

Dermatology reports
2024

Clinical signs and utility of CT PET scan in eosinophilic fasciitis?

Skin health and disease
2025

[Atypical and/or systemic dermatologic disorders related to immune checkpoint inhibitors: A review].

La Revue de medecine interne
2025

Diagnostic and prognostic performance of positron emission tomography/computed tomography in eosinophilic fasciitis: An observational multicenter retrospective study.

Journal of the American Academy of Dermatology
2025

A global retrospective study identifies higher rates of pernio in individuals with connective tissue disease.

Journal of the American Academy of Dermatology
2024

Eosinophilic Fasciitis Following Infection With COVID-19.

Irish medical journal
2025

Eosinophilic fasciitis with extensive cutaneous presentation.

Rheumatology (Oxford, England)
2024

A Case Report of Atypical Migratory Shulman Syndrome.

Cureus
2025

A Case of Eosinophilic Fasciitis.

Current rheumatology reviews
2025

Ultrasound-guided core needle biopsy of deep fascia: A cadaveric study evaluating feasibility, accuracy and reliability.

Clinical anatomy (New York, N.Y.)
2024

[Translated article] Refractory Eosinophilic Fasciitis: Good Response to Ocrelizumab in a Patient with Multiple Sclerosis Under Treatment with Natalizumab.

Actas dermo-sifiliograficas
2024

Eosinophilic Fasciitis: A Classic Presentation.

Mayo Clinic proceedings
2024

Eosinophilia-myalgia syndrome presenting with overlapping features of eosinophilic fasciitis and sarcoidal granulomas.

JAAD case reports
2024

Unmasking the Veiled Intruder: A Complicated Case of Eosinophilic Fasciitis.

Cureus
2024

Eosinophilic fasciitis: unraveling the clinical tapestry of a rare case and review of literature.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
2024

Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children.

RMD open
2024

Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace.

Dermatology reports
2024

Joint Sparing: The Key to Unlocking Early Treatment Success in Eosinophilic Fasciitis.

Cureus
2024

Power Doppler ultrasonography findings of eosinophilic fasciitis.

Rheumatology advances in practice
2024

The use of dupilumab in treatment-refractory eosinophilic fasciitis.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2024

A Severe Case of Overlap of Morphea and Eosinophilic Fasciitis after Burn Injuries.

Case reports in rheumatology
2024

Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review.

Frontiers in immunology
2024

A difficult diagnosis of eosinophilic fasciitis: A case report.

SAGE open medical case reports
2024

A case of overlap between eosinophilic fasciitis and generalized morphea.

Dermatology reports
2024

Functional and Cutaneous Treatment Outcomes With Intravenous Immunoglobulin for Eosinophilic Fasciitis: A Retrospective Study.

Journal of drugs in dermatology : JDD
2024

[Eosinophilic fasciitis: From pathophysiology to therapeutics].

La Revue de medecine interne
2024

Characteristics and management of sclerosing skin diseases during immune checkpoint inhibitor therapy: An evidence-based review.

Journal of the American Academy of Dermatology
2024

Eosinophilic Fasciitis in a 68-Year-Old Female.

Cureus
2024

Juvenile eosinophilic fasciitis: a single center case series.

Pediatric rheumatology online journal
2024

Eosinophilic Fasciitis Illustrated by 18 F-FDG PET/CT.

Clinical nuclear medicine
2024

Eosinophilic fasciitis following COVID-19: A case series of 3 patients.

JAAD case reports
2023

Is there a Role for Anti-IL-5 Therapies in Eosinophilic Fasciitis?

Mediterranean journal of rheumatology
2023

Eosinophilic Fasciitis Presenting as Chronic Nonspecific Symptoms in a Young Adult.

Oxford medical case reports
2023

Role of ultrasound in guiding the biopsy site in eosinophilic fasciitis.

Rheumatology and immunology research
2023

The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study.

Frontiers in medicine
2024

Groove sign in eosinophilic fasciitis.

QJM : monthly journal of the Association of Physicians
2023

The first case of SARS-CoV-2-induced eosinophilic fasciitis.

Modern rheumatology case reports
2023

The clinical challenge of refractory eosinophilic fasciitis.

Porto biomedical journal
2023

Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners.

Annales de dermatologie et de venereologie
2023

Eosinophilic Fasciitis Possibly Provoked by Exercise.

Skinmed
2023

Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review.

Cancers
2023

High-resolution musculoskeletal ultrasonography and elastography for eosinophilic fasciitis diagnosis and follow-up: a case-based review.

Rheumatology international
2023

Eosinophilic fasciitis in a young male auto mechanic exposed to organic solvents.

Reumatismo
2023

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab.

JAAD case reports
2023

Utility of magnetic resonance imaging in the diagnosis of eosinophilic fasciitis: A multicenter retrospective cohort study.

Journal of the American Academy of Dermatology
2024

Eosinophilic fasciitis in eosinophilic granulomatosis with polyangiitis.

Rheumatology (Oxford, England)
2023

Immunologic and nonimmunologic sclerodermal skin conditions - review.

Frontiers in immunology
2023

Diagnostic imaging for eosinophilic fasciitis: A systematic review.

JAAD international
2023

Eosinophilic Fasciitis: A Rare Mimicker of Systemic Sclerosis.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2023

Diffuse fasciitis with eosinophilia in boys: a case-based review.

Rheumatology international
2023

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics.

Pharmaceuticals (Basel, Switzerland)
2023

Mepolizumab for refractory eosinophilic fasciitis: a retrospective analysis from two tertiary care centres.

Clinical and experimental rheumatology
2023

Tocilizumab in the Treatment of Eosinophilic Fasciitis: A Case Study and Review of Literature.

Mediterranean journal of rheumatology
2023

Eosinophilic fasciitis difficult to differentiate from scleroderma: A case report.

World journal of clinical cases
2023

Diagnostic Utility of Magnetic Resonance Imaging in Eosinophilic Fasciitis: A Case Report and Review of Literature.

Cureus
2023

Eosinophil-related diseases during treatment with glucagon-like peptide one receptor (GLP-1 RA): a case report and review of the literature.

Clinical rheumatology
2023

Eosinophilic fasciitis following SARS-CoV-2 vaccination.

JAAD case reports
2023

Clinical characteristics and risk factors of patients with eosinophilic fasciitis associated with pleural effusion.

Scientific reports
2023

Eosinophilic fasciitis may present as a paraneoplastic syndrome of hematological malignancies-A systematic review.

JAAD international
2023

Eosinophilic Fasciitis Presenting as an Ichthyosiform Eruption of the Bilateral Ankles.

Case reports in dermatology
2023

[Clinical characteristics, ultrasonic diagnosis, treatment and outcomes of eosinophilic fasciitis: a retrospective single-center analysis of 45 cases].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
2023

Additional Diagnoses to Consider in Eosinophilic Fasciitis.

The American journal of medicine
2023

Clinical and histopathological features of hypereosinophilic syndrome with cutaneous involvement: The Mayo Clinic Experience.

Journal of cutaneous pathology
2023

Eosinophilic Fasciitis: Current and Remaining Challenges.

International journal of molecular sciences
2023

[Immune checkpoint inhibitor-induced eosinophilic fasciitis: a case report and literature review].

Zhonghua nei ke za zhi
2023

[Paraneoplastic syndromes in rheumatology].

Zeitschrift fur Rheumatologie
2023

Autoimmune comorbidities and antibody markers associated with eosinophilic fasciitis.

JAAD international
2023

The impact of skin disfigurement in patients with autoimmune connective tissue disorders on quality of life, willingness-to-pay, and time trade-off: A cross-sectional analysis.

JAAD international
2023

Successful treatment of eosinophilic fasciitis with the anti-IL5 receptor monoclonal antibody benralizumab.

Clinical and experimental rheumatology
2022

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT.

Frontiers in medicine
2022

An Unusual Presentation of a Rare Disease: Eosinophilic Fasciitis.

Cureus
2023

Eosinophilic Fasciitis Without Skin Sclerosis.

The Journal of rheumatology
2023

Lichen planus associated with eosinophilic fasciitis outside the setting of chronic graft-versus-host disease.

Annales de dermatologie et de venereologie
2022

[Eosinophilic dermatoses].

Dermatologie (Heidelberg, Germany)
2022

Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases.

Clinical, cosmetic and investigational dermatology
2022

Gleich syndrome and eosinophilic fasciitis overlap successfully treated with mepolizumab.

The Journal of dermatology
2022

An unusual case of eosinophilia, myalgia and skin contractures: Shulman's disease revisited.

Medical journal, Armed Forces India
2023

Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanisms.

Rheumatology (Oxford, England)
2023

Dystrophic calcinosis in eosinophilic fasciitis.

Clinical rheumatology
2022

Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.

Advances in rheumatology (London, England)
2022

Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis.

Journal of the American Academy of Dermatology
2022

Dupilumab for treatment of eosinophilic fasciitis.

Clinical and experimental dermatology
2022

The groove sign in eosinophilic fasciitis.

Clinical rheumatology
2022

Hidden in Plain Sight: Eosinophilic Fasciitis.

The American journal of medicine
2022

Eosinophilic Fasciitis: A Rare and Challenging Diagnosis in a Free Clinic Setting.

Cureus
2023

Eosinophilic fasciitis induced by certolizumab pegol: association or coincidence?

Clinical and experimental rheumatology
2022

Application of ultrasound in a case of eosinophilic fasciitis mimicking stiff-person syndrome.

Neuromuscular disorders : NMD
2022

Eosinophilic Fasciitis with Concurrent Necrobiotic Granulomatous Dermatitis Related to Checkpoint Inhibition Therapy.

Journal of immunotherapy and precision oncology
2022

MRI Findings of Eosinophilic Fasciitis.

Journal of the Belgian Society of Radiology
2024

[Imaging of eosinophilic fasciitis in ultrasound and MRI (magnetic resonance imaging): a case report].

Zeitschrift fur Rheumatologie
2022

Clinical guide to eosinophilic fasciitis: straddling dermatology and rheumatology.

Expert review of clinical immunology
2023

Efficacy of methotrexate for steroid-resistant eosinophilic fasciitis with delayed start of treatment: a case report.

International journal of dermatology
2022

Eosinophilic Fasciitis and Smoldering Multiple Myeloma: An Exceptional Association in Young Adults.

Cureus
2022

Eosinophilic Fasciitis with Hypereosinophilia as the Initial Clinical Manifestation of Peripheral T-Cell Lymphoma, Not Otherwise Specified.

Internal medicine (Tokyo, Japan)
2022

Methotrexate injection site reactions: Case report and literature review.

JAAD case reports
2022

Recalcitrant digital calcinosis cutis successfully treated with intralesional sodium thiosulfate under digital nerve blockade.

BMJ case reports
2021

Refractory eosinophilic fasciitis successfully treated with infliximab: A case report.

Journal of scleroderma and related disorders
2022

Tocilizumab in the treatment of eosinophilic fasciitis: Case report and literature review.

Revista clinica espanola
2022

Sclerotic skin disease development following COVID-19 vaccination.

JAAD case reports
2021

Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab.

Mediterranean journal of rheumatology
2021

Eosinophilic fasciitis: experience with a patient and review of the potential mimics.

Acute medicine
2022

Eosinophilic fasciitis induced by a game of drumming probably via type 2 innate immunity.

International journal of rheumatic diseases
2022

Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management.

Critical reviews in immunology
2021

Eosinophilic fasciitis (Shulman disease) with clinical, imaging and pathological correlation.

BMJ case reports
2022

Baricitinib for Refractory Eosinophilic Fasciitis: Myth or Reality?

The Journal of rheumatology
2021

Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.

European journal of dermatology : EJD
2022

UVA-1 phototherapy as adjuvant treatment for eosinophilic fasciitis: in vitro and in vivo functional characterization.

International journal of dermatology
2021

Controversy around the morphea.

Postepy dermatologii i alergologii
2021

Diagnosis and treatment of eosinophilic fasciitis: Report of two cases.

World journal of clinical cases
2021

Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin.

Nature
2021

Characteristics and Outcomes of Eosinophilic Fasciitis-Associated Monoclonal Gammopathy.

JAMA dermatology
2021

Eosinophilic fasciitis as a paraneoplastic syndrome in melanoma.

JAAD case reports
2022

Eosinophilic Fasciitis Unmasking a Lung Cancer.

The American journal of medicine
2021

Eosinophilic Fasciitis With a Malignant Outcome.

Journal of medical cases
2021

Systemic mesalazine treatment prevents spontaneous skin fibrosis in PLK2-deficient mice.

Naunyn-Schmiedeberg's archives of pharmacology
2021

Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy.

The American journal of case reports
2021

sQuiz your knowledge! Eosinophilic fasciitis.

European journal of dermatology : EJD
2021

Successful Treatment With Baricitinib in a Patient With Refractory Eosinophilic Fasciitis.

The Journal of rheumatology
2021

Complete reversibility of pembrolizumab-induced eosinophilic fasciitis without corticosteroids: A case report.

SAGE open medical case reports
2021

Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.

Clinical rheumatology
2022

Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis.

Journal of the American Academy of Dermatology
2021

Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review.

Rheumatology international
2021

Musculoskeletal ultrasound as a diagnostic tool for eosinophilic fasciitis and correlation with magnetic resonance imaging findings.

International journal of rheumatic diseases
2022

Biologic treatment outcomes in refractory eosinophilic fasciitis: A systematic review of published reports.

Journal of the American Academy of Dermatology
2021

Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature.

Medicine
2021

The enigmatic fascia: eosinophilic fasciitis.

Journal of osteopathic medicine
2021

Not just eosinophilic fasciitis.

Journal of medicine and life
2021

Eosinophilic fasciitis (Shulman syndrome), a rare entity and diagnostic challenge, as a manifestation of severe chronic graft-versus-host disease: a case report.

Journal of medical case reports
2021

The place of 18F FDG PET/CT in the management of patients with eosinophilic fasciitis: a case report.

Reumatismo
2022

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review.

The Journal of dermatological treatment
2021

Eosinophilic fasciitis induced by natalizumab in a patient affected by multiple sclerosis.

Indian journal of dermatology, venereology and leprology
2021

Eosinophilic fasciitis in a pregnant woman with corticosteroid dependence and good response to infliximab.

Rheumatology international
2021

18F-FDG PET/CT and MRI findings of Shulman syndrome also known as eosinophilic fasciitis.

European journal of nuclear medicine and molecular imaging
2020

Eosinophilic Fasciitis - Clinical Features and Therapeutic Management.

Acta dermatovenerologica Croatica : ADC
2021

Skin puckering and edema during durvalumab therapy.

JAAD case reports
2020

A "groovy" diagnosis: Eosinophilic fasciitis.

Clinical case reports
2021

Nivolumab-induced plaque morphea in a malign melanoma patient.

Journal of cosmetic dermatology
Ver todos os 728 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Fasceíte eosinofílica.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Fasceíte eosinofílica e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

A causa exata subjacente da afecção ainda é classificada como desconhecida pelos catálogos de genética médica. Até o momento, não foram catalogados genes causadores específicos nem variantes patogênicas no banco de dados ClinVar.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

8 publicações do grafo RarasNet (PubMed) · 7 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. [Shulman syndrome: An atypical presentation of a rare disease].
    Revista medica del Instituto Mexicano del Seguro Social2026PMID 41774868
  2. ORPHA:3165
    Orphanet
  3. GARD:6351
    GARD (NIH)
  4. Q2325206
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Fasceíte eosinofílica. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/fasceite-eosinofilica

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Fasceíte eosinofílica

ORPHA:3165 · MONDO:0009175
Prevalência
Unknown
Herança
Unknown
CID-10
M35.4 · Fasciíte (eosinofílica) difusa
CID-11
Ensaios
1 ativos
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0264005
EuropePMC
Wikidata
Wikipedia
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Genética mendeliana
fonte: OMIM
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara